These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 23364471)
1. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation. Yokota S; Hikasa Y; Mizushima H Pharmacology; 2013; 91(3-4):135-44. PubMed ID: 23364471 [TBL] [Abstract][Full Text] [Related]
2. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation. Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736 [TBL] [Abstract][Full Text] [Related]
3. The effects of imidazoline agents on the aggregation of human platelets. Pinthong D; Songsermsakul P; Rattanachamnong P; Kendall DA J Pharm Pharmacol; 2004 Feb; 56(2):213-20. PubMed ID: 15005880 [TBL] [Abstract][Full Text] [Related]
4. Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets. Yokota S; Hikasa Y; Shimura I; Kusunose S Am J Vet Res; 2013 Mar; 74(3):395-402. PubMed ID: 23438114 [TBL] [Abstract][Full Text] [Related]
5. Effects of imidazoline and nonimidazoline α-adrenoceptor agonists and antagonists, including xylazine, medetomidine, dexmedetomidine, yohimbine, and atipamezole, on aggregation of feline platelets. Matsukawa T; Hikasa Y Am J Vet Res; 2020 Feb; 81(2):159-171. PubMed ID: 31985287 [TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of platelet α2-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses. Hikasa Y; Masuda K; Asakura Y; Yamashita Y; Sato C; Kamio M; Miura A; Taniguchi T; Minamizuru N Eur J Pharmacol; 2013 Nov; 720(1-3):363-75. PubMed ID: 24120658 [TBL] [Abstract][Full Text] [Related]
7. Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Grant JA; Scrutton MC Br J Pharmacol; 1980; 71(1):121-34. PubMed ID: 6110451 [TBL] [Abstract][Full Text] [Related]
8. Effect of imidazoline drugs on human blood platelet aggregation. Petrusewicz J; Kaliszan R Thromb Haemost; 1985 Dec; 54(4):784-7. PubMed ID: 2868542 [TBL] [Abstract][Full Text] [Related]
9. The effects of alpha adrenergic agents on human platelet aggregation. Hsu CY; Knapp DR; Halushka PV J Pharmacol Exp Ther; 1979 Mar; 208(3):366-70. PubMed ID: 34707 [TBL] [Abstract][Full Text] [Related]
10. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors. Olmos G; Kulkarni RN; Haque M; MacDermot J Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577 [TBL] [Abstract][Full Text] [Related]
11. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation. Lanza F; Cazenave JP Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964 [TBL] [Abstract][Full Text] [Related]
12. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice. Andurkar SV; Gendler L; Gulati A Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands. Boronat MA; Olmos G; García-Sevilla JA Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of alpha-adrenoceptor agonists on human retinal microvessel diameter. Spada CS; Nieves AL; Burke JA; Wheeler LA; Woodward DF J Ocul Pharmacol Ther; 2001 Jun; 17(3):255-77. PubMed ID: 11436946 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study. Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760 [TBL] [Abstract][Full Text] [Related]
16. Adrenaline inhibits adenosine diphosphate induced intravascular aggregation of rat platelets through stimulation of alpha 2 adrenoceptors. Oyekan AO; Botting JH Cardiovasc Res; 1991 May; 25(5):431-7. PubMed ID: 1677313 [TBL] [Abstract][Full Text] [Related]
17. Potentiating effect of adrenaline on adenosine diphosphate-induced reduction in rabbit circulating platelet count: inhibition by dihydroergotoxine. Holmes IB Thromb Haemost; 1979 Aug; 42(2):641-8. PubMed ID: 41335 [TBL] [Abstract][Full Text] [Related]
18. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation. Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823 [TBL] [Abstract][Full Text] [Related]
19. Effect of 781094, a new selective alpha-adrenoceptor antagonist, on the aggregatory responses of human blood platelets and on binding of [3H]-dihydroergocryptine to these cells. Kerry R; Scrutton MC Br J Pharmacol; 1983 Jun; 79(2):401-7. PubMed ID: 6140040 [TBL] [Abstract][Full Text] [Related]
20. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine. Mustonen P; Savola J; Lassila R Thromb Res; 2000 Aug; 99(3):231-7. PubMed ID: 10942789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]